The primary resistance mechanisms include mutations in FCY2 , encoding cytosine permease (which mediates drug uptake), and mutations in FCY1 , encoding cytosine deaminase (required for 5-FC activation) (Longley et al., 2003
The continued evolution of peptide-based therapies promises expanded treatment options for metabolic disorders
Explore BPC-157 Therapy Tesamorelin Tesamorelin may be discussed with eligible patients focused on body composition, visceral fat, metabolic health, and physician-guided healthy-aging goals
Gutzwiller JP, Drewe J, Gke B, Schmidt H, Rohrer B, Lareida J, et al
Vitamin B12 Benefits for Hair: Whats the Link Between Vitamin B12 and Hair Loss
Most standard titration protocols reach therapeutic maintenance dose within 4-6 weeks of once-weekly injections